XXVII EFMC International Symposium on Medicinal Chemistry

Live

September 4 - 8

The XXVll EFMC International Symposium on Medicinal Chemistry is organised by the Société de Chimie Thérapeutique (SCT), on behalf of the European Federation for Medicinal Chemistry and Chemical Biology (EFMC).

The symposium will take place in Nice, France from September 4-8, 2022.  The organisers are confidently planning for a presential event, with hybrid options if the situation will require it. Participants will be requested to comply to the COVID-19 safety & health guidelines which will be applicable at the time of the event.

The EFMC is the main organisation for the European Medicinal Chemistry and Chemical Biology community, with 26 member societies and about 7.500 members. Its biennial EFMC-ISMC is a key symposium in the field of medicinal chemistry and drug discovery and it traditionally attracts around 1.000 participants both from industry and academia. The most recent EFMC-ISMC meeting took place in Slovenia (Ljubljana, 2018), while the edition initially planned for Basel, Switzerland in 2020 has been run as a Virtual Event in 2021.

The 2022 programme will cover advances in drug discovery in major therapeutic areas, including bacterial and viral infections, with a particular attention to current and emerging viral pandemics, but also neurodegenerative and cardiovascular diseases, rare diseases and cancer. EFMC-ISMC 2022 will also feature most recent advances in new technologies such as the exploitation of RNA as drug target, artificial intelligence in drug discovery, natural products-based drug discovery, DNA encoded libraries applications and the development of covalent drugs, PROTACs and molecular glues. Innovative approaches in medicinal chemistry will be included such as the development of immunomodulating compounds or the application of affinity selection – mass spectrometry for drug discovery. In a series of dedicated sessions, the interface between chemical biology and drug discovery will be highlighted, including topics such as in vivo chemistry for target discovery and validation, molecular imaging, and photochemical approaches. Finally, particular emphasis will again be put on first time disclosures and recent highlights in medicinal chemistry.

Nori Morita and Sascha Hartmann, Directors of Business Development at Symeres, will be present at this event. Russ Thomas, Head of Business Development at Symeres, and Miia Kovalainen, Head of Business Development at Admescope, will also be there.

More info click here

 
 

Development Centres of Excellence Network Lead Optimization Hit Generation Lead Optimization
 
 
 
 
 

Development Centres of Excellence Network Lead Optimization Hit Generation Lead Optimization
 
 
 
Scroll to top